Other studies using transgenic mouse models have shown that Shh-MB tumor cells produce TGF-β, which leads to reduced CD8 T lymphocyte expansion and activation, limiting anti-tumor cytotoxic activity65. The gene discussed is TGFB1; the disease is neoplasm.